Stocks and Investing Stocks and Investing
Thu, April 27, 2023
Wed, April 26, 2023

Ed Arce Maintained (AKBA) at Hold with Increased Target to $2 on, Apr 26th, 2023


Published on 2024-10-28 03:03:47 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Hold with Increased Target from $1.25 to $2 on, Apr 26th, 2023.

Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources